Investigational heart failure therapy seeks to stimulate body's natural healing response

(University of Minnesota Medical School) The University of Minnesota is the first institution in the state to participate in the phase III clinical trial for CardiAmp Therapy. Previous clinical studies of this therapy have been promising and have shown improvements in patients' quality of life and heart function.